Back to RIGL
D. E. Shaw & Co., Inc. RIGL Position History
Rigel Pharmaceuticals, Inc.
Quarters held
14
Latest value
$12.9M
Q2 2026
Peak value
$12.9M
First seen
Q2 2022
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2022 | $2.4M |
| Q2 2022 | $1.5M |
| Q3 2022 | $3.9M |
| Q3 2022 | $1.6M |
| Q4 2022 | $3.7M |
| Q4 2022 | $1.3M |
| Q3 2025 | $1.1M |
| Q3 2025 | $7.6M |
| Q4 2025 | $6.6M |
| Q4 2025 | $11.6M |
| Q1 2026 | $6M |
| Q1 2026 | $6M |
| Q2 2026 | $8.3M |
| Q2 2026 | $12.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $12.9M | 329.3K | — | — |
| Q2 2026 | $8.3M | 213.3K | — | — |
| Q1 2026 | $6M | 222.1K | — | — |
| Q1 2026 | $6M | 223.5K | — | — |
| Q4 2025 | $11.6M | 270.3K | — | — |
| Q4 2025 | $6.6M | 154.0K | — | — |
| Q3 2025 | $7.6M | 269.3K | — | — |
| Q3 2025 | $1.1M | 37.2K | — | — |
| Q4 2022 | $1.3M | 868.6K | — | — |
| Q4 2022 | $3.7M | 2.48M | — | — |
| Q3 2022 | $1.6M | 1.38M | — | — |
| Q3 2022 | $3.9M | 3.27M | — | — |
| Q2 2022 | $1.5M | 1.31M | — | — |
| Q2 2022 | $2.4M | 2.16M | — | — |
Other funds holding RIGL
$40.7M
$40.7M
$30.3M
$22.4M
$22.4M
$15.1M
$13.8M